デフォルト表紙
市場調査レポート
商品コード
1541688

直接給与生菌(DFM)市場レポート:製品タイプ、家畜、形態、地域別、2024年~2032年

Direct Fed Microbials Market Report by Product Type (Lactic Acid Bacteria, Bacillus, and Others), Livestock (Swine, Poultry, Ruminants, Aquatic Animals, and Others), Form (Dry, Liquid), and Region 2024-2032

出版日: | 発行: IMARC | ページ情報: 英文 142 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.13円
直接給与生菌(DFM)市場レポート:製品タイプ、家畜、形態、地域別、2024年~2032年
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 142 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

直接給与生菌(DFM)の世界市場規模は2023年に13億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに21億4,000万米ドルに達し、2024年から2032年の間に5.19%の成長率(CAGR)を示すと予測しています。

直接給与生菌(DFM)は、動物の健康と生産性を向上させるために、生きた天然由来のバクテリアを含む飼料サプリメントです。DFMはpHを下げ、腸内病原体を減らし、腸細胞の増殖を刺激して、動物の腸の完全性を維持します。乳酸やマイコトキシンなどの望ましくない化合物を無害化し、免疫システムを強化します。また、αアミラーゼ、セルラーゼ、プロテアーゼなどの有益な酵素を大量に生産することで、消化管内の微生物バランスを整える働きもあります。現在、世界中で動物の間でさまざまな疾病が蔓延しているため、DFMの需要が増加しています。

直接給与生菌(DFM)市場動向:

世界の畜産人口の増加とともに、その高タンパク質含有量による鶏肉需要の高まりが、市場を牽引する重要な要因のひとつとなっています。これに加えて、代謝の促進、腸内微生物叢の維持、アンモニア生成、腸内毒素の中和といったDFMの利点に対する大衆の意識の高まりが、業界の投資家に有利な成長機会を提供しています。さらに、薬剤耐性菌がヒトに感染するリスクを低減するため、抗生物質による成長促進剤を直接給餌微生物に置き換える動きが活発化しています。これは、急成長する畜産業とともに、市場の成長に寄与しています。さらに、市場の主なプレーヤーは、DFM製品の調達、加工、流通を効率的に管理するために、ブロックチェーンやモノのインターネット(IoT)技術を導入するための研究開発(R&D)活動に幅広く投資しています。また、市場リーチを拡大するため、さまざまなマーケティング戦略にも注力しています。これとは別に、クロストリジウム、下痢、胃腸疾患による動物の死亡率を減らすためにDFMの利用が増加していることが、市場の成長を後押ししています。

本レポートで扱う主な質問

  • 世界の直接給与生菌(DFM)市場の市場規模は?
  • 2024-2032年の世界の直接給与生菌(DFM)市場の予想成長率は?
  • 世界の直接給与生菌(DFM)市場を牽引する主要因は何か?
  • 世界の直接給与生菌(DFM)市場に対するCOVID-19の影響は?
  • 世界の直接給与生菌(DFM)市場の製品タイプ別内訳は?
  • 世界の直接給与生菌(DFM)市場の畜産物別の内訳は?
  • 世界の直接給与生菌(DFM)市場の形態別内訳は?
  • 世界の直接給与生菌(DFM)市場の主要地域は?
  • 世界の直接給与生菌(DFM)市場における主要プレーヤー/企業は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の直接給与生菌(DFM)市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:製品タイプ別

  • 乳酸菌
    • 市場動向
    • 市場予測
  • バチルス
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第7章 市場内訳:家畜別

    • 市場動向
    • 市場予測
  • 家禽
    • 市場動向
    • 市場予測
  • 反芻動物
    • 市場動向
    • 市場予測
  • 水生動物
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳:形態別

  • 乾燥
    • 市場動向
    • 市場予測
  • 液体
    • 市場動向
    • 市場予測

第9章 市場内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • BASF SE
    • Alltech
    • American Biosystems Inc
    • Bayer AG
    • Bio-Vet
    • Cargill Incorporated
    • Chr. Hansen A/S(Chr Hansen Holding A/S)
    • DuPont de Nemours Inc.
    • Kemin Industries
    • Koninklijke DSM N.V.
    • Lallemand Inc.
    • Novozymes A/S(Novo Holdings A/S)
    • Novus International Inc.(Mitsui & Co. Ltd)
図表

List of Figures

  • Figure 1: Global: Direct Fed Microbials Market: Major Drivers and Challenges
  • Figure 2: Global: Direct Fed Microbials Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Direct Fed Microbials Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Direct Fed Microbials Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Direct Fed Microbials Market: Breakup by Livestock (in %), 2023
  • Figure 6: Global: Direct Fed Microbials Market: Breakup by Form (in %), 2023
  • Figure 7: Global: Direct Fed Microbials Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Direct Fed Microbials (Lactic Acid Bacteria) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Direct Fed Microbials (Lactic Acid Bacteria) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Direct Fed Microbials (Bacillus) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Direct Fed Microbials (Bacillus) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Direct Fed Microbials (Other Product Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Direct Fed Microbials (Other Product Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Direct Fed Microbials (Swine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Direct Fed Microbials (Swine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Direct Fed Microbials (Poultry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Direct Fed Microbials (Poultry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Direct Fed Microbials (Ruminants) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Direct Fed Microbials (Ruminants) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Direct Fed Microbials (Aquatic Animals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Direct Fed Microbials (Aquatic Animals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Direct Fed Microbials (Other Livestocks) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Direct Fed Microbials (Other Livestocks) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Direct Fed Microbials (Dry) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Direct Fed Microbials (Dry) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Direct Fed Microbials (Liquid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Direct Fed Microbials (Liquid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: North America: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: North America: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: United States: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: United States: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Canada: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Canada: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Asia-Pacific: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Asia-Pacific: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: China: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: China: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Japan: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Japan: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: India: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: India: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: South Korea: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: South Korea: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Australia: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Australia: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Indonesia: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Indonesia: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Others: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Others: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Europe: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Europe: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Germany: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Germany: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: France: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: France: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: United Kingdom: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: United Kingdom: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Italy: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Italy: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Spain: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Spain: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Russia: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Russia: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Others: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Others: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Latin America: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Latin America: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Brazil: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Brazil: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Mexico: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Mexico: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Others: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Others: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Middle East and Africa: Direct Fed Microbials Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Middle East and Africa: Direct Fed Microbials Market: Breakup by Country (in %), 2023
  • Figure 76: Middle East and Africa: Direct Fed Microbials Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Global: Direct Fed Microbials Industry: SWOT Analysis
  • Figure 78: Global: Direct Fed Microbials Industry: Value Chain Analysis
  • Figure 79: Global: Direct Fed Microbials Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Direct Fed Microbials Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Direct Fed Microbials Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Direct Fed Microbials Market Forecast: Breakup by Livestock (in Million US$), 2024-2032
  • Table 4: Global: Direct Fed Microbials Market Forecast: Breakup by Form (in Million US$), 2024-2032
  • Table 5: Global: Direct Fed Microbials Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Direct Fed Microbials Market: Competitive Structure
  • Table 7: Global: Direct Fed Microbials Market: Key Players
目次
Product Code: SR112024A6094

The global direct fed microbials market size reached US$ 1.30 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.14 Billion by 2032, exhibiting a growth rate (CAGR) of 5.19% during 2024-2032.

Direct-fed microbials (DFMs) are feed supplements that contain live and naturally occurring bacteria to improve the health and productivity of animals. They lower the pH, reduce enteric pathogens, and stimulate intestinal cell proliferation, which maintains the gut integrity of animals. They detoxify undesirable compounds, such as lactic acid and mycotoxins, to boost the immune system. They also help provide microbial balance in the digestive tract by producing high levels of beneficial enzymes, such as alpha amylase, cellulase, and protease. At present, there is a rise in the demand for DFMs due to the growing prevalence of different diseases among animals across the globe.

Direct Fed Microbials Market Trends:

The rising demand for poultry meat due to its high protein content, along with the growing livestock population around the world, represents one of the key factors driving the market. Besides this, the increasing awareness among the masses about the benefits of DFMs, such as enhancing metabolism, maintaining microbial flora in the intestine, ammonia production, and neutralizing enterotoxin, is offering lucrative growth opportunities to industry investors. Moreover, there is an increase in the replacement of antibiotic growth promoters with direct-fed microbials to reduce the risk of transmitting drug-resistant bacteria to humans. This, along with the burgeoning livestock industry, is contributing to the growth of the market. In addition, key market players are extensively investing in research and development (R&D) activities to introduce blockchain and the internet of things (IoT) technologies for managing the procurement, processing, and distribution of DFM products effectively. They are also focusing on various marketing strategies to expand their market reach. Apart from this, the rising utilization of DFMs to reduce the mortality rate of animals due to clostridial, diarrhea, and gastrointestinal diseases is bolstering the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global direct fed microbials market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product type, livestock and form.

Breakup by Product Type:

Lactic Acid Bacteria

Bacillus

Others

Breakup by Livestock:

Swine

Poultry

Ruminants

Aquatic Animals

Others

Breakup by Form:

Dry

Liquid

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Alltech, American Biosystems Inc, Bayer AG, Bio-Vet, Cargill Incorporated, Chr. Hansen A/S (Chr Hansen Holding A/S), DuPont de Nemours Inc., Kemin Industries, Koninklijke DSM N.V., Lallemand Inc., Novozymes A/S (Novo Holdings A/S) and Novus International Inc. (Mitsui & Co. Ltd).

Key Questions Answered in This Report

  • 1. How big is the global direct fed microbials market?
  • 2. What is the expected growth rate of the global direct fed microbials market during 2024-2032?
  • 3. What are the key factors driving the global direct fed microbials market?
  • 4. What has been the impact of COVID-19 on the global direct fed microbials market?
  • 5. What is the breakup of the global direct fed microbials market based on the product type?
  • 6. What is the breakup of the global direct fed microbials market based on the livestock?
  • 7. What is the breakup of the global direct fed microbials market based on the form?
  • 8. What are the key regions in the global direct fed microbials market?
  • 9. Who are the key players/companies in the global direct fed microbials market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Direct Fed Microbials Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Lactic Acid Bacteria
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Bacillus
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Livestock

  • 7.1 Swine
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Poultry
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Ruminants
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Aquatic Animals
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Form

  • 8.1 Dry
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Liquid
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 BASF SE
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Alltech
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 American Biosystems Inc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Bayer AG
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Bio-Vet
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Cargill Incorporated
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Chr. Hansen A/S (Chr Hansen Holding A/S)
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 DuPont de Nemours Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Kemin Industries
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
    • 14.3.10 Koninklijke DSM N.V.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
    • 14.3.11 Lallemand Inc.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Novozymes A/S (Novo Holdings A/S)
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
    • 14.3.13 Novus International Inc. (Mitsui & Co. Ltd)
      • 14.3.13.1 Company Overview
      • 14.3.13.2 Product Portfolio